Direct-to-consumer drug pricing could compete with prescription insurance

A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the private prescription drug insurance model, researchers say.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup